Pymedix

Pymedix specializes in radiology DICOM image processing application software, specifically tools designed to automate and enhance workflows for medical imaging analysis. Their primary focus is on software solutions like Autofuse, which integrates and processes imaging data to improve diagnostic efficiency. These tools are built to comply with DICOM standards, ensuring seamless interoperability within radiology environments.

Pymedix is based in the United States, which means its devices are subject to FDA oversight. Since the company’s products fall under FDA Class II classification, they require 510(k) clearance for market authorization and must also comply with UDI (Unique Device Identification) registration. The FDA’s regulatory databases, such as the 510(k) and UDI listings, document these authorised devices.

Pymedix’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s UDI (Unique Device Identifier) registry. These registries confirm that individual products, such as Autofuse, have undergone the necessary authorisation processes (e.g., 510(k) clearance) and are tracked under UDI requirements for traceability and compliance.

Pymedix’s devices are classified as FDA Class II, which is the second-highest risk category for medical devices. This classification applies to software like Autofuse, which automates imaging fusion and analysis but does not pose significant risk to patients. Class II devices require 510(k) clearance (demonstrating substantial equivalence to a predicate device) before they can be legally marketed in the US.

Pymedix’s software, such as Autofuse, is designed to automate the fusion and processing of medical imaging data (e.g., CT, MRI, or X-ray scans) to streamline diagnostic workflows. By integrating disparate imaging files into a unified format, these tools help radiologists and clinicians reduce manual effort, improve accuracy, and accelerate interpretation—all while maintaining compliance with DICOM standards for interoperability.